Investing
But the sector still makes up just 15% of overall investment in the digital health market.
While the tech-enabled primary care provider set the initial pricing of its shares at $14 apiece, prices are climbing in the early hours of its IPO.
Report predicts growth will be driven by provider operations and alternative care companies.
The company's tech platform enables same-day prescription deliveries.
Formerly known as Enzyme Health, the company's strategy is comprised of two major avenues: telehealth staffing opportunities for practitioners, and a scalable telehealth platform for companies.
The Israeli company is developing a two-pronged offering comprised of an in-hospital device and a companion cloud software tool.
DoctorLogic's software offering includes a range of tools designed to support website traffic and new patient acquisition for healthcare practices of varying specialties.
IQVIA led the round with participation from Windham Ventures and other existing investors.
Gentem distinguishes its end-to-end billing and revenue cycle platform by offering upfront payments to its clients.
Arboretum Ventures, Vetnure Investors, Capital Midwest Fund and OSF HealthCare participated in this round.